Immunoproteasome-selective inhibitors: the future of autoimmune diseases?

Future Med Chem. 2020 Feb;12(4):269-272. doi: 10.4155/fmc-2019-0299. Epub 2020 Jan 27.

Authors

Chong Zhang¹, Huajian Zhu¹, Jiaan Shao¹, Ruoyu He², Jianjun Xi², Rangxiao Zhuang², Jiankang Zhang¹

Affiliations

¹ School of Medicine, Zhejiang University City College, Hangzhou, 310015, Zhejiang Province, PR China.
² Department of Pharmaceutical Preparation, Hangzhou Xixi Hospital, Hangzhou, 310023, Zhejiang Province, PR China.

PMID: 31983229
DOI: 10.4155/fmc-2019-0299

No abstract available

Keywords: autoimmune diseases; design; immunoproteasome; selective inhibitor.

Publication types

Editorial

MeSH terms

Autoimmune Diseases / drug therapy*
Autoimmune Diseases / immunology
Autoimmune Diseases / metabolism
Humans
Proteasome Endopeptidase Complex / chemistry
Proteasome Endopeptidase Complex / immunology
Proteasome Endopeptidase Complex / metabolism*
Proteasome Inhibitors / chemistry
Proteasome Inhibitors / pharmacology*

Substances

Proteasome Inhibitors
Proteasome Endopeptidase Complex